Skip to content

Krystal Biotech, Inc. KRYS Income taxes receivable

Income taxes receivable at other companies

Merck & Co. logo
Merck & Co.MRK
$5.7B+46.2%
Moderna logo
ModernaMRNA
Biogen logo
BiogenBIIB
Viatris logo
ViatrisVTRS

Other financials

Income statement

See full
Revenue$116.4M+31.9%
Operating income$53.7M+48.1%
Net income$55.9M+56.5%
EPS (diluted)$1.83+52.5%

Balance sheet

See full
Cash & equivalents$501.3M+62.4%
Total debt$9.1M-5.7%
Total equity$1.3B+29.7%
Total assets$1.4B+30.0%

Cash flow

See full
Operating cash flow$80.4M+160%
CapEx$7.1M+15.2%
Free cash flow$73.2M+196%

Valuation

See full
Market cap$10.26B+45.4%
Enterprise value$9.77B+44.2%
P/E45.6×-11.3×
P/S24.6×+3.4×

Profitability

See full
Operating margin42.8%+10.2pp
Net margin53.9%+16.7pp
FCF margin56.9%+16.5pp

Returns & leverage

See full
Return on equity19.9%+6.0pp
Debt / equity0.0×
Current ratio9.5×-0.2×

Where this comes from

Reported directly by Krystal Biotech, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PrepaidTaxes.

The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Krystal Biotech, Inc.'s income taxes receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Krystal Biotech, Inc.'s income taxes receivable?
Krystal Biotech, Inc. (KRYS) reported income taxes receivable of $10.64M in Q1 2026.
What does income taxes receivable mean?
Tax refunds or credits that the company is owed by the government.
How do you interpret income taxes receivable?
An increase indicates a potential cash inflow from tax authorities, while a decrease suggests the realization of those assets.
How does income taxes receivable compare across companies?
Standard across all sectors; usually a minor component of current assets unless significant tax credits are involved.